Hydra Biosciences Obtains $17,016,100 Series C Round

  • Feed Type
  • Date
    3/13/2008
  • Company Name
    Hydra Biosciences
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139
  • Company Description
    Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels.
  • Website
    http://www.hydrabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,016,100
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. This is the final tranche of a series C round totaling $34 million.
  • M&A Terms
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Bioventures Investors
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Polaris Venture Partners

By posting a comment, you agree to our terms and conditions.